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ScienceDirectMetabolic pathways leading to benzylisoquinoline and
monoterpene indole alkaloids in plants are revealing
remarkable new reactions. Understanding of the enzymes
involved in alkaloid biosynthesis provides access to a variety of
applications in biocatalysis and bioengineering. In chemo-
enzymatic settings, plant biocatalysts can transform medically
important scaffolds. Additionally, synthetic biologists are taking
alkaloid pathways as templates to assemble pathways in
microorganisms that are tailored to the needs of medicinal
chemistry. In light of these many recent discoveries, it is
expected that plants will continue to be a source of novel
biocatalysts for the foreseeable future.
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Introduction
The versatile secondary metabolism of plants has been a rich
source for natural products throughout human history. While
the darkest recesses of bacterial and fungal secondary
metabolism are becoming illuminated at a rapid pace [1],
biocatalysts from plants have been more difficult to track
down. The last missing step in morphine biosynthesis has
only been identified in 2015 [2,3,4], more than 200
years after the opiate was isolated by Sertu¨rner. The vanillin
synthase from vanilla pods has remained elusive until
2014 [5] although vanillin is an integral part of everyday life
as a food ingredient and fragrance. The late steps of vinblas-
tine and taxol biosynthesis, both widely used cancer drugs,
currentlyremainamystery,not for lackofeffort.Discoveryof
these biosynthetic enzymes can facilitate production of
naturally occurring, high-value compounds. Additionally,
plants carry out chemistry that is not observed in other
organisms, making these enzymes sought-after biocatalysts.
Pathway elucidation is straightforward when one gene
exposes a region in the genome where all other genes ofCurrent Opinion in Chemical Biology 2016, 31:22–30 the pathway of interest are clustered [6]. Gene clustering is
a typical feature in microorganisms, but unfortunately,
such clusters are found inconsistently in plants [7]. Hence,
plant genes have been historically assigned to chemical
transformations one at a time, a tedious process even when
the chemistry is well understood from isotopic feeding and
other biochemical studies [8]. If not genomically, plant
pathway genes may functionally cluster, which has been
revealed by transcriptome sequencing and co-expression
analysis [9]. These techniques have enabled a series of
important gene discoveries [3,10,11,12].
This review focuses on recently unravelled enzymatic
transformations involved in alkaloid biosynthesis, primar-
ily in Madagascar periwinkle (Catharanthus roseus) and
opium poppy (Papaver somniferum), and their potential for
synthetic biology and biocatalysis. The presented
enzymes from plant secondary metabolism can be broadly
classified into scaffold generating enzymes that change
the connectivity of carbon–carbon bonds and tailoring
enzymes that, for instance, oxidize, acylate, glycosylate,
or methylate these scaffolds. However, the boundaries
can be blurred between these two categories [13].
Scaffold formation
Iridoid synthase: adding a new twist to reduction
Synthetic chemists must envy the ease by which enzymes
establish complex, cyclic molecular scaffolds from achiral
precursors. A remarkable, reductive terpene cyclization
[10,14] is involved in the reaction sequence linking the
monoterpene geranyl pyrophosphate to the universal
monoterpene indole alkaloid (MIA) precursor strictosidine
(Figure 1). Iridoid synthase from C. roseus (CrISY) catalyzes
reductive cyclization of the monoterpene 8-oxogeranial
yielding the bicyclic iridoid nepetalactol in an NADPH
dependent reaction. The reaction mechanism of CrISY is
clearly distinct from the canonical, cationic mechanism of
terpene cyclization. Although the atom connectivity sug-
gested a hetero Diels–Alder reaction, experiments with
substrate analogues were in better agreement with a reduc-
tion/Michael addition sequence [15]. The substrate 8-oxo-
geranial [16] and geranic acid, which resembles the
expected enolate intermediate after hydride transfer, could
be co-crystallized with the enzyme revealing the likely
substrate binding mode and catalytic features [17]. The
structure of CrISY can possibly inform future enzyme
engineering efforts for the generation of alternative iridoid
scaffolds.
Pictet–Spenglerases: versatile biocatalysts
Iridoids and other alkaloid precursors are often combined
together by Pictet–Spenglerases in reactions that connectwww.sciencedirect.com
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Key reactions and products in MIA biosynthesis. The scaffold-forming enzymes ISY [10] and STR [18] catalyse key C–C bond forming reactions in
MIA biosynthesis. THAS [32] and T3O [11,45] catalyse important redox-based tailoring steps. Un-filled arrows indicate steps that have not been
elucidated on the enzyme level yet.amines and carbonyls to alkaloid scaffolds [18]. The
Pictet–Spengler condensation of tryptamine and the iri-
doid-derived aldehyde secologanin, for instance, is the
key reaction in the biosynthesis of MIAs [19] (Figure 1).
Strictosidine, the product of this reaction, is then further
processed — often beyond recognition — to a myriad of
downstream products, like strychnine, camptothecin, and
vinblastine.
The Pictet–Spenglerase strictosidine synthase (STR) is a
workhorse for biocatalytic applications [18] and shows
interesting substrate promiscuity. Alternative indole al-
kaloid scaffolds were generated in a chemo-enzymatic
approach that converts chemo-synthetic precursors with
purified STR1 from Rauwolfia serpentina [20]. From 1H-
indole-1-ethanamine and secologanin, STR1 synthesized
a configurational isomer of strictosidine with a pipera-
zino[1,2-a]indole scaffold, in which the indole ring iswww.sciencedirect.com ‘flipped’ (Figure 2a). The engineering of STR also show-
cases how targeted mutations can remove roadblocks for
biosynthetic diversification [21]. Hairy root cultures of C.
roseus were transformed with halogenase genes rebH and
rebF resulting in the production of halogenated trypto-
phan analogues in vivo that were envisioned to enter the
MIA pathway. STR could be coerced into accepting 5-
and 6-halogenated tryptamine by active-site mutation
V214M [22,23]. As a result, halogenated alkaloids could
be isolated from root tissue co-transformed with the
halogenase genes and the mutated STR [21]. These
halogenated alkaloid analogues were diversified even
further by using the bromo-indole functionalities as han-
dles for selective derivatization [23,24] (Figure 2b).
As part of a pathway leading to the important drug
molecules codeine, morphine, noscapine, and berberine,
the Pictet–Spenglerase norcoclaurine synthase (NCS)Current Opinion in Chemical Biology 2016, 31:22–30
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attracted considerable attention (Figure 3). In contrast to
STR, the NCSs from Thalictrum flavum and Coptis japon-
ica show exceptional substrate promiscuity for various
aldehydes including a wide range of phenylacetalde-
hydes and even a few aliphatic aldehydes [25–27].
The aldehyde promiscuity of these Pictet–Spenglerases
has been harnessed in biocatalytic approaches for the
generation of chiral benzylisoquinolines [25–27] and
could be enhanced by mutagenesis [28]. By combining
TfNCS with a transaminase for aldehyde precursor gen-
eration and reacting the initial isoquinoline product with
formaldehyde, a tetrahydroprotoberberine alkaloid was
formed in a one-pot reaction from dopamine [29]
(Figure 2c). Altogether, these results augur well for
future work on the diversification of MIAs and BIAs
relying on natural or engineered substrate promiscuity
of Pictet–Spenglerases.
Racemic benzylisoquinolines resulting from non-enzy-
matic Pictet–Spengler or analogous reactions could be
converted into optically pure material by berberine bridge
enzyme (BBE) [30]. In the BIA pathway towards the
antibiotic berberine (Figure 3), BBE closes a ring be-
tween an N-methylated isoquinoline and a phenol via
FAD-dependent oxidation of the N-methyl group
(Figure 2d). Gandomkar and co-workers observed that,
although BBE was unable to cyclize synthetic N-ethyl
derivatives of reticuline, they were efficiently dealkylated
[30]. With a range of N-ethyl benzylisoquinolines, BBE
performed kinetic resolutions yielding dealkylated pro-
ducts in excellent enantiomeric excess (>98%).
Tailoring enzymes
THAS: deciding the fate of a labile intermediate
Little is known about the scaffold rearrangements in
MIA biosynthesis that follow on from the Pictet–Spen-
gler condensation catalysed by STR (Figure 1). A cas-
cade of reactions is triggered by deglycosylation of
strictosidine, which generates a chemically  labile dia-
ldehyde (strictosidine aglycone). In an intramolecular
Schiff base formation, the tetracyclic strictosidine agly-
cone spontaneously closes to pentacyclic cathenamine
and isomers [19,31]. At this biosynthetic branch point,
only the path towards heteroyohimbine alkaloids has
been elucidated: Tetrahydroalstonine synthase (THAS)(Figure 2 Legend) Recently discovered or engineered biochemical reaction
biosynthetic pathway can be used to make a novel piperazino[1,2-a]indole s
broader spectrum of substrates to be turned over, including 5 and 6 haloge
further derivatized by cross-coupling reactions [21–23]. (c) The Pictet–Spen
treatment to yield a more complex alkaloid [29]. (d) S-Reticuline can enter t
the methylamine to a ring yielding S-scoulerine [30]. In morphine biosynthe
chalcone reductase is responsible for epimerization of the morphine biosyn
protecting group during noscapine biosynthesis [38]. (f) The P450 T3O per
rearranges to the imine alcohol, or forms the imine-alcohol directly [11,45].
involved in the biosynthesis of vincamine. (g) Arabidopsis forms an unprece
epoxide formation and subsequently control cyclization to form either the sp
www.sciencedirect.com channels the metabolic flux towards this scaffold by
reducing the iminium form of cathenamine [32]
(Figure 1). By controlling the stereoconfiguration of
the methyl group in cathenamine and of the incoming
hydride, THAS selectively catalyzes formation of one
out of four possible stereoisomers. Pending further
mechanistic and structural investigations, the resem-
blance of THAS to sinapyl alcohol dehydrogenase
[32] suggests a catalytic mechanism different from that
of typical imine reductases [33].
Reticuline epimerization: an unprecedented fusion
As with MIA biosynthesis, numerous dehydrogenases are
involved in BIA metabolism and one of them performs an
epimerization reaction that has eluded researchers for
decades. Epimerization of reticuline — the last missing
step in morphine biosynthesis — has recently been de-
scribed by three independent groups led by Graham,
Facchini, and Smolke [2,3,4] (Figures 2d, 3). While
the Pictet–Spenglerase NCS generates the S-configura-
tion, morphine has the R-configuration at this carbon.
Therefore, an epimerization reaction is required in mor-
phine biosynthesis. S- to R-reticuline epimerase (STORR)
is an unprecedented fusion of an N-terminal cytochrome
P450 domain that oxidizes the tertiary amine in S-reticu-
line to the corresponding iminium and a C-terminal reduc-
tase that performs an NADPH dependent reduction to the
R-configuration (Figure 2d). When compared to other
dehydrogenases in MIA metabolism, the reductase seg-
ment of STORR belongs to the aldo-keto reductase class,
similar to codeinone reductase, whereas the BIA enzymes
salutaridine reductase [34] and sanguinarine reductase [35]
belong to the short-chain dehydrogenase (SDR) class. In
the final step leading to the BIA noscapine, the newly
discovered SDR noscapine synthase was shown to oxidize
the narcotine hemiacetal to the lactone noscapine [36].
Interestingly, this enzyme was originally discovered as part
of a 10 gene cluster in the opium poppy genome [37].
Noscapine synthesis: acetylation orchestrates oxidation
Earlier in noscapine synthesis in opium poppy, the action
of three P450 oxidases is orchestrated by transient acety-
lation, reminiscent of protective group usage in organic
synthesis [38]. P450 enzymes hydroxylate the noscapine
precursor S-N-methylcanadine at two positions. The third
hydroxylation only takes place when one of the others from plants that are highlighted in this review. (a) STR from the MIA
caffold structure [20]. (b) Site-directed mutagenesis of STR allows a
nated tryptamine analogues. These halogenated derivatives can be
glerase NCS from BIA biosynthesis can be coupled with formaldehyde
wo different routes. In berberine biosynthesis, BBE oxidatively closes
sis, an unprecedented fusion protein consisting of a P450 and a
thetic intermediate reticuline [2,3,4]. (e) An acetyl group acts as a
forms a net-hydration either by generating an amine epoxide that
 This reaction is integral to vinblastine biosynthesis, and also may be
dented a-ketonitrile scaffold [46]. (h) In Brassica, P450s catalyse
irobrassinol or cyclobrassinol product [47].
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Key reactions and products in BIA biosynthesis. The BIA pathway harbours numerous enzymes that can be exploited for biocatalysis purposes.
Both the Pictet–Spenglerase NCS (Figure 2c) [25–29] and the flavoenzyme BBE [30] have been used in biocatalytic applications. The last missing
step in morphine biosynthesis, STORR, has been recently elucidated (Figure 2d) [2,3,4].hydroxyl groups is acetylated and yields a labile carbino-
lamine (Figure 2e). Then, opening of the carbinolamine
triggers a skeletal rearrangement. The carbonyl group
originating from the carbinolamine and the hydroxyl
group liberated by deprotection of the acetyl group form
a hemiacetal. Interestingly, there is no obvious chemical
requirement for the presence of the acetyl group. It is
tempting to speculate that acetylation/deacetylation may
be conserved as a vestigial trait due to the stringent
substrate specificity of these enzymes that is unlikely
to change simultaneously [38].
P450s in C. roseus: hydroxylation and beyond
P450 enzymes also play important roles in the MIA
pathway of C. roseus. On the way from geranyl-pyrophos-
phate to secologanin, 7-deoxyloganic acid-7-hydroxylase
[39] and 7-deoxyloganetic acid synthase introduce a hy-
droxyl group, and oxidize a methyl group to a carboxylate,
respectively [40,41]. Several steps later, P450 enzymes
T16H1, T16H2, [42] and T19H act on tabersonine [43]
by introducing hydroxyl groups. Although the chemical
transformations involved are not unusual, complete
knowledge of these enzymes is crucial for pathway re-
constitution approaches [41,44].
A transformation of 16-methoxy-tabersonine, in what
seems to be a P450 catalysed hydration of an enamine
double bond, has less chemical precedence and may play
a role also in scaffold formation [11,45] (Figure 2f). This
transformation is apparently triggered by oxidation of theCurrent Opinion in Chemical Biology 2016, 31:22–30 enamine double bond to an epoxide by 16-methoxy-
tabersonine 3-oxidase (T3O), independently discovered
by the groups of O’Connor and de Luca. In planta, the
amino epoxide likely opens to an imino alcohol that 16-
methoxy-tabersonine-3-reductase (T3R) reduces to the
amino alcohol (Figure 2f) [45]; alternatively, the enzyme
may generate the imino alcohol directly [11]. Kellner
et al. have proposed an intriguing hypothesis about an
alternative, multistep rearrangement that takes place in
the absence of the subsequent downstream reductase
[45]. NMR spectra of an in vitro reaction conducted with
T3O and 16-methoxy-tabersonine demonstrate that the
product resembles vincamine, an alkaloid not present in
C. roseus but in the related genus Vinca (Figure 2f). Future
experiments are needed to show whether the T3O trig-
gered rearrangement can indeed explain the biosynthesis
of this additional vinca alkaloid scaffold.
Brassicaceae: new P450s in well-known plants
Co-expression analysis on the transcriptome level had a
share in all P450 discoveries mentioned above. In combi-
nation with metabolomics studies, RNAseq analysis has
aided not only in gene, but also in natural product
discovery in a plant where new natural products may
have been least expected [46]. Arabidopsis tissues under
pathogen-stress revealed consistent upregulation of
CYP82C2. When this gene was knocked out, the biosyn-
thetic intermediate indole-3-carbonyl nitrile (ICN) accu-
mulated (Figure 2g). CYP82C2 apparently hydroxylates
ICN at C4 of the indole ring. By using this enzyme as baitwww.sciencedirect.com
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Discovery of new plant-derived enzymes allows reconstitution of complex pathways in heterologous organisms such as Nicotiana benthamiana
and Saccharomyces cerevisiae. Black arrows indicate newly introduced enzymatic steps, grey arrows indicate steps that are not new to the
heterologous host but had to be enhanced by introducing additional genes, un-filled arrows indicate reactions that were not modified, and purple
arrows indicate off-pathway reactions that were reduced by knocking-out or inhibiting host genes. Accessory enzymes like cytochrome P450
reductases were also introduced but are not shown. (a) The central MIA biosynthetic intermediate strictosidine has been produced in S. cerevisiae
[44]. Reconstitution of the same pathway in N. benthamiana has proven fruitful for candidate verification [41]. (b) The late stage MIA intermediate
vindoline, a direct precursor for the anti-cancer agent vinblastine, has been produced in seven steps from tabersonine in S. cerevisiae [11]. (c)
Opiates from the morphine pathway have been produced de novo in S. cerevisiae [4,51,52,53].for co-expression analysis, two P450s and a dehydroge-
nase were discovered that synthesize ICN from trypto-
phan via an oxime and a cyanohydrin (Figure 2g). The a-
ketonitrile functional group of ICN is highly unusual in
natural products.
Other indolic compounds occur in crucifers widely culti-
vated as food plants and their biosynthesis provides
another example where P450s act beyond their usual
scope of reactivity. The presence of spirobrassinin and
cyclobrassinin in Brassica rapa has recently been traced
back to the action of two P450 enzymes catalysing alter-
native S-heterocyclizations on brassinin [47] (Figure 2h).
An epoxide introduced by the P450s at C2 and C3 of the
indole ring is intramolecularly attacked by a dithiocarba-
mate moiety either at C2 or C3, yielding cyclobrassinin or
spirobrassinin. Since the enzymes CYP71CR2 and
CYP71CR1 almost exclusively yielded one or the other
product under in vitro conditions, it can be assumed thatwww.sciencedirect.com they catalyse regioselective cyclization in addition to
epoxidation.
Pathway reconstitution
An incentive for elucidating the biosynthesis of plant
natural products is not only the exploitation of individual
plant biocatalysts, but also the assembly of entire meta-
bolic pathways in new hosts. The industrial production of
the plant terpenoid artemisinin for use as an antimalarial
drug [48], which is partially conducted in engineered
yeast, foreshadows a bright future for plant pathway
reconstitutions [49]. Alkaloids, too, have been the target
of pathway reconstitutions in inexpensively cultured
microorganisms like yeast or in the efficiently transform-
able model plant Nicotiana benthamiana [50]. While yeast
can provide scalable biosynthetic methods, pathway
reconstitutions in N. benthamiana are useful to function-
ally verify gene candidates in an orthogonal plant host.
The MIA precursor strictosidine, for instance, has beenCurrent Opinion in Chemical Biology 2016, 31:22–30
28 Biocatalysis and biotransformationproduced in N. benthamiana in seven steps starting from
the externally supplied intermediate iridodial thus vali-
dating several gene candidates [41]. The earlier part of
the pathway starting from primary metabolites also func-
tioned, but not in combination with the later enzymes.
Although Saccharomyces cerevisiae seems even more chal-
lenging as a host, here, strictosidine production was
successfully achieved by introducing 14 genes from the
MIA pathway, seven accessory genes and three gene
deletions [44] (Figure 4a). Gene deletions helped to
redirect the metabolic flux away from undesired off-
pathway metabolites, for instance sesquiterpenes, to
the desired target strictosidine.
Initial successes are promising, but reconstructed path-
ways have to become considerably more efficient and
several genes need to be discovered before production of
complex indole alkaloid drugs like vinblastine becomes
feasible in microorganisms. Vindoline, a late precursor of
vinblastine, has been biosynthesized in seven steps from
the MIA tabersonine in yeast [11] (Figure 4b) but
missing genes between strictosidine and tabersonine
obstruct the connection to primary metabolism. Pathway
reconstruction of BIAs [4,51,52,53] is one step ahead
since morphine biosynthesis has been fully elucidated
(Figure 4c). Nevertheless, yields of thebaine or hydro-
codone are only in the range of micrograms per litre and
several orders of magnitude lower than necessary to
compete with isolation from plants [4]. In the future,
metabolic bottlenecks may be removed by tuning tran-
scriptional promotors, optimizing codon usage, blocking
side reactions, upregulating the precursor synthesis, en-
gineering the enzymes, or perhaps by laboratory evolu-
tion of strains.
Conclusion
Important gaps in our understanding of plant metabolism
have been filled in recent years but even larger gaps
remain. When fundamentally new chemistry is discov-
ered in a thoroughly investigated model plant like A.
thaliana [46], this suggests that we are only scratching
the surface of the metabolic complexity present in more
than 200 000 species of flowering plants. With every
newly discovered enzyme, gene discovery efforts contrib-
ute to a rapidly growing set of biocatalysts that can render
chemical syntheses more efficient and sustainable. The
impact of plant biocatalysts will likely be amplified when
structural and mechanistic studies provide the framework
for enzyme engineering that can significantly broaden
their catalytic scope [54].
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